Global mRNA Vaccines and Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global mRNA Vaccines and Therapeutics market size will reach 3,300.43 Million USD in 2025 and is projected to reach 1,520.59 Million USD by 2032, with a CAGR of -10.48% (2025-2032). Notably, the China mRNA Vaccines and Therapeutics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
mRNA (messenger RNA) vaccines and therapeutics are a groundbreaking class of medical treatments and preventive measures that use synthetic strands of messenger RNA to instruct cells in the body to produce specific proteins or trigger immune responses. In the context of vaccines, mRNA vaccines have gained significant attention for their role in protecting against infectious diseases, such as COVID-19. They work by introducing a small piece of synthetic mRNA that codes for a harmless part of the target pathogen, prompting the immune system to produce an immune response. Similarly, in therapeutics, mRNA can be used to instruct cells to create therapeutic proteins, offering potential treatments for various medical conditions, including genetic diseases and cancer. mRNA technology has shown great promise due to its flexibility, rapid development potential, and adaptability in responding to emerging health challenges, marking a significant advancement in the fields of vaccination and medical treatment.
The major global suppliers of mRNA Vaccines and Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of mRNA Vaccines and Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global mRNA Vaccines and Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the mRNA Vaccines and Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of mRNA Vaccines and Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of mRNA Vaccines and Therapeutics Include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
mRNA Vaccines and Therapeutics Product Segment Include:
Vaccines
Therapeutics
mRNA Vaccines and Therapeutics Product Application Include:
Disease Prevention Market
Tumor Immunity Market
Protein Replacement Therapy Market
Regenerative Therapy Market
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global mRNA Vaccines and Therapeutics Industry PESTEL Analysis
Chapter 3: Global mRNA Vaccines and Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global mRNA Vaccines and Therapeutics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global mRNA Vaccines and Therapeutics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global mRNA Vaccines and Therapeutics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, mRNA Vaccines and Therapeutics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global mRNA Vaccines and Therapeutics market size will reach 3,300.43 Million USD in 2025 and is projected to reach 1,520.59 Million USD by 2032, with a CAGR of -10.48% (2025-2032). Notably, the China mRNA Vaccines and Therapeutics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
mRNA (messenger RNA) vaccines and therapeutics are a groundbreaking class of medical treatments and preventive measures that use synthetic strands of messenger RNA to instruct cells in the body to produce specific proteins or trigger immune responses. In the context of vaccines, mRNA vaccines have gained significant attention for their role in protecting against infectious diseases, such as COVID-19. They work by introducing a small piece of synthetic mRNA that codes for a harmless part of the target pathogen, prompting the immune system to produce an immune response. Similarly, in therapeutics, mRNA can be used to instruct cells to create therapeutic proteins, offering potential treatments for various medical conditions, including genetic diseases and cancer. mRNA technology has shown great promise due to its flexibility, rapid development potential, and adaptability in responding to emerging health challenges, marking a significant advancement in the fields of vaccination and medical treatment.
The major global suppliers of mRNA Vaccines and Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of mRNA Vaccines and Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global mRNA Vaccines and Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the mRNA Vaccines and Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of mRNA Vaccines and Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of mRNA Vaccines and Therapeutics Include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
mRNA Vaccines and Therapeutics Product Segment Include:
Vaccines
Therapeutics
mRNA Vaccines and Therapeutics Product Application Include:
Disease Prevention Market
Tumor Immunity Market
Protein Replacement Therapy Market
Regenerative Therapy Market
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global mRNA Vaccines and Therapeutics Industry PESTEL Analysis
Chapter 3: Global mRNA Vaccines and Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global mRNA Vaccines and Therapeutics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global mRNA Vaccines and Therapeutics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global mRNA Vaccines and Therapeutics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, mRNA Vaccines and Therapeutics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 mRNA Vaccines and Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 mRNA Vaccines and Therapeutics Product by Type
- 1.2.1 Vaccines
- 1.2.2 Therapeutics
- 1.3 mRNA Vaccines and Therapeutics Product by Application
- 1.3.1 Disease Prevention Market
- 1.3.2 Tumor Immunity Market
- 1.3.3 Protein Replacement Therapy Market
- 1.3.4 Regenerative Therapy Market
- 1.4 Global mRNA Vaccines and Therapeutics Market Size Analysis (2020-2032)
- 1.5 mRNA Vaccines and Therapeutics Market Development Status and Trends
- 1.5.1 mRNA Vaccines and Therapeutics Industry Development Status Analysis
- 1.5.2 mRNA Vaccines and Therapeutics Industry Development Trends Analysis
- 2 mRNA Vaccines and Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 mRNA Vaccines and Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global mRNA Vaccines and Therapeutics Market Analysis by Country
- 4.1 Global mRNA Vaccines and Therapeutics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global mRNA Vaccines and Therapeutics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global mRNA Vaccines and Therapeutics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.5 China mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.6 France mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.14 India mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa mRNA Vaccines and Therapeutics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global mRNA Vaccines and Therapeutics Market Revenue by Key Suppliers (2021-2025)
- 5.2 mRNA Vaccines and Therapeutics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 mRNA Vaccines and Therapeutics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 mRNA Vaccines and Therapeutics Market Analysis by Type
- 6.1 Global mRNA Vaccines and Therapeutics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global mRNA Vaccines and Therapeutics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Moderna Therapeutics
- 7.1.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Portfolio
- 7.1.3 Moderna Therapeutics mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 CureVac
- 7.2.1 CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 CureVac mRNA Vaccines and Therapeutics Product Portfolio
- 7.2.3 CureVac mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Translate Bio
- 7.3.1 Translate Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Translate Bio mRNA Vaccines and Therapeutics Product Portfolio
- 7.3.3 Translate Bio mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 BioNTech
- 7.4.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 BioNTech mRNA Vaccines and Therapeutics Product Portfolio
- 7.4.3 BioNTech mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Sangamo Therapeutics
- 7.5.1 Sangamo Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Portfolio
- 7.5.3 Sangamo Therapeutics mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Argos Therapeutics
- 7.6.1 Argos Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Argos Therapeutics mRNA Vaccines and Therapeutics Product Portfolio
- 7.6.3 Argos Therapeutics mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 In-Cell-Art
- 7.7.1 In-Cell-Art Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 In-Cell-Art mRNA Vaccines and Therapeutics Product Portfolio
- 7.7.3 In-Cell-Art mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 eTheRNA
- 7.8.1 eTheRNA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 eTheRNA mRNA Vaccines and Therapeutics Product Portfolio
- 7.8.3 eTheRNA mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Ethris
- 7.9.1 Ethris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Ethris mRNA Vaccines and Therapeutics Product Portfolio
- 7.9.3 Ethris mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Tiba Biotechnology
- 7.10.1 Tiba Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Portfolio
- 7.10.3 Tiba Biotechnology mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 mRNA Vaccines and Therapeutics Industry Chain Analysis
- 8.2 mRNA Vaccines and Therapeutics Product Downstream Application Analysis
- 8.2.1 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global mRNA Vaccines and Therapeutics Revenue and Forecast by Application (2020-2032)
- 8.3 mRNA Vaccines and Therapeutics Typical Downstream Customers
- 8.4 mRNA Vaccines and Therapeutics Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 B
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
